Docket Room.
SB 1495·TN·senate

Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.

Signed into LawFiled Dec 23, 2025
Sponsor: Haile (R)
Latest Action

Pub. Ch. 888

May 18, 2026

Summary

The bill amends state law to include three additional drug manufacturers—Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc.—alongside Purdue Pharma in the list of firms the attorney general may pursue for opioid-related claims. It updates two code sections and takes effect immediately, expanding the pool of companies that could be held liable for opioid harms.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get an email when SB 1495 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SB 1495 free

Or ask your AI assistant about SB 1495 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice